05242017Headline:

Philadelphia, Pennsylvania

HomePennsylvaniaPhiladelphia

Jamie Sheller

FDA warns of foot, leg amputations with Invokana

   The Food and Drug Administration recently required Johnson & Johnson to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations. Final results from two clinical trials showed leg and foot amputations occurred […]

Jamie Sheller

Study-XARELTO MAY CAUSE MORE BLEEDING THAN PRADAXA

According to an observational study published in JAMA Internal Medicine, people taking Xarelto (rivaroxaban) may be more likely to have a serious bleeding event than those taking Pradaxa (dabigatran). Johnson and Johnson (J&J) is facing more the 15,000 Xarelto lawsuits. […]

Jamie Sheller

Xarelto Injury Update

To date, more than 9,000 lawsuits have been filed across the country against the makers and distributors of Xarelto. Currently, more than 7,000 cases are pending in New Orleans, Louisiana in the multi-district  (MDL) overseen by U.S. District Court Judge […]

Jamie Sheller

Invokana and Kidney Injury

Lawsuits filed in both the US and Canada allege the use of Invokana caused damage to patients’ kidneys but that the makers of Invokana (known generically as canagliflozin) failed to warn patients about that risk. According to reports, in the […]

Jamie Sheller

Viagra®, or its twin drug, Revatio® and increased risk of Melanoma

If you have taken Viagra®, or its twin drug, Revatio®, for a high blood pressure condition known as pulmonary arterial hypertension, then you should also be aware that this medication may be associated with a significantly increased risk for developing […]

Sheller, P.C.

Xarelto Bleeding Antidote Not Approved by FDA

An antidote intended for uncontrolled bleeding linked to blood thinners was not approved by the U.S. Food and Drug Administration (FDA), according to Portola Pharmaceuticals, the maker. At the current time there is no reversal agent for uncontrolled bleeding linked […]

Sheller, P.C.

Risperdal Lawsuit Featured on “Full Measure” TV

There is no disputing that medicine has saved countless lives. But, there is also no disputing that prescription drugs are a leading cause of death in our over-prescribed country. Each year, drugs that are properly prescribed in the U.S. cause […]

Sheller, P.C.

Xarelto Sales Continue to Rise Despite Lawsuits

There has been a mounting number of suits being filed against Bayer, the makers of the blood thinner Xarelto, with allegations contending the drug causes severe internal bleeding that leads to hospitalizations, serious injury and even death. But, interestingly, that […]

Sheller, P.C.

Risperdal Gynecomastia Lawsuit – $70 Million Jury Verdict in Philadelphia Court

In an unprecedented jury verdict, Andrew Yount, a Tennessee plaintiff was awarded $70 million in a Risperdal trial. Andrew Yount v. Janssen Pharmaceuticals, the fifth Risperdal case, awarded $70 million in damages for emotional distress and physical disfigurement that was […]

Sheller, P.C.

Risperdal Gynecomastia Lawsuit: “One-Off” Not Indication of Looming Global Settlement

The most recent Risperdal case settled before trial, but that doesn’t mean a global settlement is underway in the mass tort, according to a lawyer handing the litigation. Moffat v. Janssen Pharmaceuticals, settled in May for an undisclosed amount. The […]